Immunotherapy of Liver Diseases

Immunotherapy of Liver Diseases

Saved in:

Bibliographic Details
Main Authors:	Dechun Feng, YinYing Lu, Xiaoni Kong, Feng Li
Format:	Article
Language:	English
Published:	Wiley 2019-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2019/9343505
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inflammation in Liver Diseases
by: Dechun Feng, et al.
Published: (2018-01-01)

Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
by: Li-Chun Lu, et al.
Published: (2023-04-01)

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
by: Yuehong Chen, et al.
Published: (2019-01-01)

Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases
by: Taoyuan M Beninato, et al.
Published: (2024-12-01)

Developing Costimulatory Molecules for Immunotherapy of Diseases /
by: Mir, Manzoor Ahmad
Published: (2015)

Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice
by: Meng Li, et al.
Published: (2018-01-01)

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
by: Fengyuan Li, et al.
Published: (2016-01-01)

Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
by: Xinjun Lu, et al.
Published: (2024-11-01)

A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
by: Bing Feng, et al.
Published: (2025-01-01)

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
by: Changzhou Cai, et al.
Published: (2021-01-01)

Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy
by: Yufan CHEN, et al.
Published: (2025-01-01)

Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention
by: Wenhui Hu, et al.
Published: (2025-12-01)

Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study
by: Ying Di, et al.
Published: (2024-08-01)

Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)

Metabonomics Research Progress on Liver Diseases
by: Mengqian Yu, et al.
Published: (2017-01-01)

Identification of biomarkers associated with coronary artery disease and non-alcoholic fatty liver disease by bioinformatics analysis and machine learning
by: Chuan Lu, et al.
Published: (2025-01-01)

Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention
by: You Chen, et al.
Published: (2021-01-01)

A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
by: Manqing Peng, et al.
Published: (2024-12-01)

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy
by: Yajing Zhang, et al.
Published: (2013-01-01)

Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01)

Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease
by: Benoît Leclerc, et al.
Published: (2013-01-01)

Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01)

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01)

Liver diseases: epidemiology, causes, trends and predictions
by: Can Gan, et al.
Published: (2025-02-01)

Correction: A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
by: Manqing Peng, et al.
Published: (2025-01-01)

Gastroenterological Cancer and Immunotherapy
by: Xiaoping Wang, et al.
Published: (2018-01-01)

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
by: Florence Vallelian, et al.
Published: (2023-01-01)

Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)
by: Xiguang Chen, et al.
Published: (2025-01-01)

Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens
by: Jie Jiang, et al.
Published: (2025-02-01)

Stem Cells and Liver Diseases
by: Zongyi Hu, et al.
Published: (2019-01-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
by: Anne Mills, et al.
Published: (2023-06-01)

NLRP3 activation maintains intestinal epithelial barrier and reduces liver injury in alcoholic liver disease mice
by: Shi‐Qing Li, et al.
Published: (2024-12-01)

Increased Serum Angiotensin II Is a Risk Factor of Nonalcoholic Fatty Liver Disease: A Prospective Pilot Study
by: Yue Li, et al.
Published: (2019-01-01)

Cytokines and Liver Diseases
by: Herbert Tilg
Published: (2001-01-01)

Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening
by: Dan Zhao, et al.
Published: (2025-02-01)

Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
by: Yingying Zhao, et al.
Published: (2019-01-01)

Cancer Immunotherapy: Theory and Application
by: Guobing Chen, et al.
Published: (2018-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation
by: Masahiro Ohira, et al.
Published: (2025-01-01)